| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/11/2007 | WO2007004425A1 Tablet containing poorly soluble active ingredient |
| 01/11/2007 | WO2007004244A1 Salts or complexes of methyl donors with phytic acid or its derivatives and method for the synthesis thereof |
| 01/11/2007 | WO2007004061A1 Syntheses and preparations of polymorphs of crystalline aripiprazole |
| 01/11/2007 | WO2007003965A1 Substituted cyclohexyl derivatives as nk-3 receptor antagonists |
| 01/11/2007 | WO2007003941A1 Modulation of autophagy by calpain inhibition |
| 01/11/2007 | WO2007003767A2 Novel chemical compounds and the uses thereof as a medicine |
| 01/11/2007 | WO2006120481A3 2,3-substituted fused bicyclic pyrimidin-4(3h)-ones which modulate the function of the vanilloid-1 receptor (vr1) |
| 01/11/2007 | WO2006116485A3 Trpv1 agonist compounds and methods for making and using the same |
| 01/11/2007 | WO2006105527A3 Amylin and amylin agonists for treating psychiatric diseases and disorders |
| 01/11/2007 | WO2006095173A3 Medical uses of 39-desmethoxyrapamycin and analogues thereof |
| 01/11/2007 | WO2006094209A3 N-benzimidazolylalkyl-substituted amide sirtuin modulators |
| 01/11/2007 | WO2006089053A3 Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives |
| 01/11/2007 | WO2006079731A3 Use of cacao polyphenols for treating a prostate hyperplasia, a specific cacao extract and applications |
| 01/11/2007 | WO2006072792A3 Compounds which bind to the active site of protein kinase enzymes |
| 01/11/2007 | US20070010671 Novel quinazoline derivatives and methods of treatment related to the use thereof |
| 01/11/2007 | US20070010554 Aryl substituted pyridines and the use thereof |
| 01/11/2007 | US20070010549 Imidazo(4,5-b)pyridine-derivatives as inducible no-synthase inhibitors |
| 01/11/2007 | US20070010535 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological atates |
| 01/11/2007 | US20070010534 Novel compounds |
| 01/11/2007 | US20070010529 Nitrogenous heterocyclic compounds and medical use thereof |
| 01/11/2007 | US20070010528 excellent efficacy, oral absorbability, sustained effect, fewer side effects; for thrombosis; anticoagulants; N-(4-((4-( 3-((6-chloro-2-naphthyl)sulfonyl)propanoyl)-1-piperazinyl)methyl)-3-methyl-1,3-thiazol-2(3H)-ylidene)-N-methylamine |
| 01/11/2007 | US20070010526 Therapeutic isoquinoline compounds |
| 01/11/2007 | US20070010522 Triazolo[1,5-c]pyrimidines and pyrazolo[1,5-c]pyrimidines useful as a2a adenosine receptor antagonists |
| 01/11/2007 | US20070010517 Pharmaceutical salts of reboxetine |
| 01/11/2007 | US20070010515 [1,2,4] Triazolo [1,5, a] pyrimidin-2-ylurea derivative and use thereof |
| 01/11/2007 | US20070010508 Use of 10-hydroxy-10,11-dihydrocarbamazepine derivatives for the treatment of affective disorders |
| 01/11/2007 | US20070010507 Compounds useful in the therapy of alzheimer's disease and formulations containing them |
| 01/11/2007 | US20070010479 Administering pyrimidine nucleotide precursor where respiratory chain dysfunction is caused by mutation, deletion, or rearrangement of mitochondrial DNA, cytotoxic cancer chemotherapy agents, aging |
| 01/11/2007 | US20070010475 Use of spongosine (2-methoxyadenosein) for the treatment of pain, in particular hyperalgesia |
| 01/11/2007 | US20070010457 Caspase inhibitors and uses thereof |
| 01/11/2007 | US20070010437 Amino acid based compositions for the treatment of pathological conditions distinguised by insufficient mitochondrial function |
| 01/11/2007 | US20070010010 Method for efficient transfer of human blastocyst-derived stem cell (hbs cells) from a feeder-supported to a feeder-free culture system |
| 01/11/2007 | US20070009971 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 01/11/2007 | US20070009933 PGC-1beta, a novel PGC-1 homologue and uses therefor |
| 01/11/2007 | US20070009600 Antidepressant dosage form |
| 01/11/2007 | US20070009588 comprises fentanyl as active ingredient, pressure-sensitive adhesive base, and tackifier resin; pressure-sensitive adhesive base comprising polyisobutylene and styrene/isoprene/styrene block copolymer; easily produced, has long-term continuity, and is excellent in adhesion and conformability to skin |
| 01/11/2007 | US20070009554 Biologically active hemagglutinin from type a clostridium botulinum and methods of use |
| 01/11/2007 | US20070009546 Isolated nucleic acid; screening for antibacterial compounds |
| 01/11/2007 | US20070009513 Novel method of screening |
| 01/11/2007 | US20070009432 Boat tropanes |
| 01/11/2007 | DE10394354T5 Pfanzliche Formulierung, die Centella Asiatica und Sesamum Indicum enthält, als Gehirn-Tonikum Pfanzliche formulation Centella Asiatica and Sesamum indicum contains, as a brain tonic |
| 01/11/2007 | DE102005028862A1 Substituierte Heterocyclen, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen Substituted heterocycles, their use as a medicament as well as pharmaceutical compositions containing them |
| 01/11/2007 | CA2614315A1 Activator of peroxisome proliferator activated receptor d |
| 01/11/2007 | CA2614076A1 Humanised antibodies specific for nogo-a and pharmaceutical uses thereof |
| 01/11/2007 | CA2613435A1 Amino-5-(6-membered)heteroarylimidazolone compounds and the use thereof for .beta.-secretase modulation |
| 01/11/2007 | CA2613345A1 Compositions ameliorating a reduced diurnal activity and/or depressive symptoms |
| 01/11/2007 | CA2613343A1 Compositions comprising arachidonic acid and docosapentaenoic acid for ameliorating reduced higher brain functions resyktubg from organic brain lesions |
| 01/11/2007 | CA2613192A1 Histamine h3 receptor agents, preparation and therapeutic uses |
| 01/11/2007 | CA2613045A1 Amino-5-(5-membered)heteroarylimidazolone compounds and the use thereof for .beta.-secretase modulation |
| 01/11/2007 | CA2611867A1 Substituted cyclohexyl derivatives as nk-3 receptor antagonists |
| 01/11/2007 | CA2605128A1 Syntheses and preparations of polymorphs of crystalline aripiprazole |
| 01/10/2007 | EP1741792A1 Novel ligand of g-protein-conjugated receptor protein and use thereof |
| 01/10/2007 | EP1741783A1 Human antiamyloid beta peptide antibody and antibody fragment thereof |
| 01/10/2007 | EP1741781A2 RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA) |
| 01/10/2007 | EP1741722A2 Polymorphisms in the human P2X7 gene |
| 01/10/2007 | EP1741713A2 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 01/10/2007 | EP1741703A1 Pyridone derivative |
| 01/10/2007 | EP1741702A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof |
| 01/10/2007 | EP1741697A1 Crystal comprising (2r)-2-propyloctoic acid and amine |
| 01/10/2007 | EP1741437A1 Functional food for ameliorating engogenous melatonin secretion rhythm and functional food for ameliorating circadian rhythm |
| 01/10/2007 | EP1741436A1 Strontium compound for treatment of sub-dermal soft tissue pain |
| 01/10/2007 | EP1741430A1 Remedy for psychoneurotic diseases |
| 01/10/2007 | EP1741428A2 Cell adhesion inhibitors |
| 01/10/2007 | EP1741424A2 Solid pharmaceutical dispersions with enhanced bioavailabilty |
| 01/10/2007 | EP1740614A2 Caspase-2 inhibitors and their biological applications |
| 01/10/2007 | EP1740591A1 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors |
| 01/10/2007 | EP1740587A2 Selective antagonists of a-2a- adenosine receptors |
| 01/10/2007 | EP1740585A1 Enantiomer-pure hexahydro- pyrrolocyclopenta- pyridine derivatives |
| 01/10/2007 | EP1740583A1 Oxadiazolone derivatives as ppar delta agonists |
| 01/10/2007 | EP1740577A2 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments |
| 01/10/2007 | EP1740575A2 Pyrrolidine derivatives useful as bace inhibitors |
| 01/10/2007 | EP1740573A1 Amides as bace inhibitors |
| 01/10/2007 | EP1740570A2 Novel gamma secretase inhibitors |
| 01/10/2007 | EP1740559A1 1,3,5-substituted phenyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/10/2007 | EP1740553A1 Aryl glycinamide derivatives and their use as nk1 antagonists and serotonin reuptake inhibithors |
| 01/10/2007 | EP1740552A1 2- ( arylalkoxy ) -1- phenylethylamine derivatives as nk1 antagonist and serotonin reuptake inhibitors |
| 01/10/2007 | EP1740211A2 Combinations comprising alpha-2-delta ligands and ep4 receptor antagonists |
| 01/10/2007 | EP1740204A1 Medicinal use of alpha-mannosidose |
| 01/10/2007 | EP1740202A1 Use of luteinizing hormone (lh) and chorionic gonadotropin (hcg) for proliferation of neural stem cells and neurogenesis |
| 01/10/2007 | EP1740200A1 Il-6 for therapy or prevention of chemotherapy-induced neuropathy |
| 01/10/2007 | EP1740199A1 Il6r/il6 chimera for therapy of chemotherapy-induced peripheral neuropathy |
| 01/10/2007 | EP1740198A2 Anti-aging effects of substance p |
| 01/10/2007 | EP1740195A1 Extract of nelumbinis semen for the treatment of depresssion, medicinal composite and health foods including the extract of nelumbinis semen |
| 01/10/2007 | EP1740192A2 Method for stimulating the immune, inflammatory or neuroprotective response |
| 01/10/2007 | EP1740183A1 Novel use for pde5 inhibitors |
| 01/10/2007 | EP1740178A2 Methods and compositions for the treatment, prevention or management of diysfunctional sleep and dysfunctional sleep associated with disease |
| 01/10/2007 | EP1740175A1 Use of a cgrp-antagonist combined with a serotonin-reuptake inhibitor in order to treat migraines |
| 01/10/2007 | EP1740172A2 Acetylcholinesterase inhibitors and n-methyl-d-aspartate antagonists useful in the treatment of cognitive disorders |
| 01/10/2007 | EP1572167A4 Transdermal buprenorphine dosage regimen for analgesia |
| 01/10/2007 | EP1560806B1 4-alkyl/4-alkenyl/4-alkynyl methyl/-1-arylcyclohexylamine derivatives |
| 01/10/2007 | EP1560581B1 Oromucosal formulation and process for preparing the same |
| 01/10/2007 | EP1521583B1 7,8,9,10-tetrahydro-6h-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2h-pyrrolo (2,1-b)-quinazolinone derivatives |
| 01/10/2007 | EP1453505A4 Use of pramipexole to treat amyotrophic lateral sclerosis |
| 01/10/2007 | EP1418915B1 Neuroprotective drug |
| 01/10/2007 | EP1414440B1 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands |
| 01/10/2007 | EP1406606B1 Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain |
| 01/10/2007 | EP1392320B1 17-METHYLENE-ANDROSTAN-3a-OL ANALOGS AS CRH INHIBITORS |
| 01/10/2007 | EP1353905B1 Piperidine/piperazine-type inhibitors of p38 kinase |
| 01/10/2007 | EP1244447B1 Novel methods and compositions involving opioids and antagonists thereof |
| 01/10/2007 | EP1200073B1 SELECTIVE iGluR 5? RECEPTOR ANTAGONISTS FOR THE TREATMENT OF MIGRAINE |